Comparing the Efficacy and Safety of Conventional Therapy With Conventional Therapy Combined Esketamine in the Treatment of Fibromyalgia: A Multicenter Clinical Study
Fibromyalgia is a chronic pain syndrome where current medications have limited efficacy and a slow onset of action. Esketamine shows potential as a rapid-acting analgesic, but previous low-dose studies failed to demonstrate long-term benefits. The efficacy of higher-dose ESK as an adjunctive therapy when standard treatments are insufficient remains unclear.
- Status
- recruiting
- Institution
- Beijing Tiantan Hospital
- Start date
- 2025-09-15
- End date
- 2027-08-31
- Registry ID
- NCT07230171
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.